Prothena Corp Public (PRTA) Net Equity Issued and Repurchased (2013 - 2023)
Prothena Corp Public's (PRTA) quarterly Net Equity Issued and Repurchased came in at -$33000.0 in Q2 2023, down 100.16% quarter-over-quarter from $20.7 million in Q1 2023.
Prothena Corp Public (PRTA) Net Equity Issued and Repurchased (2013 - 2023) Analysis & Trends
Prothena Corp Public's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at -$33000.0 for Q2 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$33000.0 in Q2 2023; TTM through Mar 2024 was -$33000.0, a 100.02% decrease from a year earlier, with the FY2023 full-year figure at $20.7 million, down 88.01% from the prior year.
- Net Equity Issued and Repurchased fell to -$33000.0 in Q2 2023 per PRTA's latest filing, from $20.7 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $172.6 million in Q4 2022 and bottomed at -$318000.0 in Q2 2021.
- The 3-year median for Net Equity Issued and Repurchased is $20.7 million (2023), against an average of $54.3 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -33,000.00 |
| Jun 30, 2023 | -33,000.00 |
| Mar 31, 2023 | 20.72 Mn |
| Mar 31, 2023 | 20.72 Mn |
| Dec 31, 2022 | 172.58 Mn |
| Dec 31, 2022 | 172.58 Mn |
| Jun 30, 2021 | -318,000.00 |
| Jun 30, 2021 | -318,000.00 |
| Mar 31, 2021 | 78.37 Mn |
| Mar 31, 2021 | 78.37 Mn |
| Jun 30, 2017 | -98,000.00 |
| Jun 30, 2017 | -98,000.00 |
| Mar 31, 2017 | 150.42 Mn |
| Mar 31, 2017 | 150.42 Mn |
| Jun 30, 2016 | -8,000.00 |
| Jun 30, 2016 | -8,000.00 |
| Mar 31, 2016 | 128.79 Mn |
| Mar 31, 2016 | 128.79 Mn |
| Dec 31, 2015 | -140,000.00 |
| Dec 31, 2015 | -140,000.00 |